Showing results (1061-1070 of 1,468) with videos related to

Sort By:
Pageof 147
Clinical and Experimental Immunology|July 15, 2017
Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working groupS Jolles, S Sánchez-Ramón, I Quinti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
Low-penetrance genes and their involvement in colorectal cancer susceptibilityMirjam M de Jong, Ilja M Nolte, Gerard J te Meerman, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Altered Sphingolipid Balance in Capillary Cerebral Amyloid AngiopathyNienke M de Wit, Hripsime Snkhchyan, Sandra den Hoedt, et al.
Free Radical Biology & Medicine|December 15, 2010
Association of Parkinson disease-related protein PINK1 with Alzheimer disease and multiple sclerosis brain lesionsMicha M M Wilhelmus, Susanne M A van der Pol, Quentin Jansen, et al.
EJNMMI Research|September 29, 2020
Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse modelFrans V Suurs, Si-Qi Qiu, Joshua J Yim, et al.
ESMO Open|October 26, 2017
Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rulesUrania Dafni, Dimitris Karlis, Xanthi Pedeli, et al.
Veterinary Parasitology|July 31, 2007
Field study on nematode resistance in Nelore-breed cattleP A Bricarello, L G Zaros, L L Coutinho, et al.
AIDS Research and Human Retroviruses|March 1, 1997
Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected personsS M Bruisten, P H Frissen, P Van Swieten, et al.
Blood|January 15, 1996
The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantationM J van Tol, E J Gerritsen, G G de Lange, et al.
British Journal of Cancer|November 21, 2007
A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumoursF A L M Eskens, C H Mom, A S T Planting, et al.
Pageof 147